Medical Research Future Fund releases Australian Medical Research and Innovation Priorities 2018-2020
8 NOV - The MRFF Priorities for 2018-2020 under One Health - Antimicrobial Resistance, Global Health and Health Security have been released by the Department of Health.
- One Health – Antimicrobial Resistance
There are no borders between human and animal health when it comes to antimicrobial resistance (AMR). Research into stewardship practices, diagnostic tools and new antimicrobials and vaccines that spans this divide is critical.
Australia has one of the highest rates of antibiotic use in the world. High rates of antibiotic use are associated with increasing rates of antibiotic resistance. The Australian National AMR Strategy 2015-2019 recognises that AMR is a One Health issue that requires a coordinated response in all sectors including the human health, animal health, food and agriculture sectors.
Provision of research grant opportunities that focus on collaborative multidisciplinary research to achieve better public health outcomes through the understanding of mechanisms of microbe transfer between animals and humans and by the development of strategies to reduce antibiotic use and apply novel therapeutic solutions.
- Global Health and Health Security
Global health challenges including health emergencies and pandemic preparedness, and the development and implementation of low technology preventative, diagnostic and treatment solutions are best addressed through international research collaboration.
Health is a global effort and today’s world is highly interconnected. Australians can benefit from research that addresses emerging global threats and delivers fit-for-purpose healthcare innovations that can be of secondary benefit to other nations. It is important that Australian researchers think and work globally to address shared challenges.
Creation of an Australian Global Health Challenges Research Fund that can leverage contributions from other portfolios, philanthropy and global health funds to purposefully stimulate public good research that addresses global health and health security issues of relevance to Australia. This fund could work similar to the Biomedical Translation Fund but have a not-for-profit focus.
All 4 dengue strains can circulate together, turn deadly: Study
8 NOV - Neetu Chandra Sharma
The Indian Council of Medical Research (ICMR) has confirmed that DEN 3 is circulating this year in the national capital, while the National Institute of Malaria Research (NIMR) has recently established in its research, An Epidemiological Study of Dengue and its Coinfections in Delhi, that in previous years, all the four strains were circulating together.
The mortality burden of multidrug-resistant pathogens in India: a retrospective observational study
8 NOV Via CIDRAP - Sumanth Gandra
A new study by researchers with the Center for Disease Dynamics, Economics and Policy has found a significant relationship between multidrug-resistant (MDR) bacterial infections and mortality in India.
Implementation and impact of an Antimicrobial Stewardship Program at a tertiary care centre in South India
8 NOV Via CIDRAP - Sanjeev Singh et al.,
Currently, ASPs are rare in India but are gaining momentum. This study describes ASP implementation in a large, academic, private, tertiary-care center in India.
Australia to set up $2 billion infrastructure fund for Indo-Pacific region
8 NOV - Elizabeth Roche
The Australian government announced on Thursday that it would establish the Australian Infrastructure Financing Facility for countries in the Pacific region with a $2 billion infrastructure initiative “to significantly boost Australia’s support for infrastructure development in Pacific countries and Timor-Leste”.
WHO tracking mechanism for IHR additional health measures
8 NOV - Adam Kamradt-Scott et at.,
In February, 2018, WHO in collaboration with The University of Sydney, NSW, Australia, launched a new tool to monitor compliance with the International Health Regulations (2005) (IHR 2005) requirements regarding additional health measures. The initiative is part of the WHO Secretariat's commitment to strengthening the IHR framework, which is a legally binding instrument to protect global public health and prevent unnecessary disruption to international traffic and trade; this framework has been adopted by 196 States Parties, including all 194 Member States of WHO.
Indonesia to lead global fight against pandemic zoonoses
7 NOV - Dyaning Pangestika
With the emergence of many diseases amid climate change around the globe, Indonesia has taken initiative to lead other countries in preventing pandemic zoonoses through the zoonotic disease action package (ZDAP) scheme.
Health Ministry: Monkey malaria spike due to better diagnosis, but deforestation raises risk
7 NOV - The Ministry of Health (MoH) has explained today that the spike in monkey malaria reports in the last 10 years was due to improvements in diagnosis that can differentiate between such cases and other variants that affect humans.
OECD: Interventions to reduce resistant bacteria could save lives, money
7 NOV - via CIDRAP
According to the OECD analysis, the proportion of infections caused by antibiotic-resistant bacteria could increase from 17% in 2015 to 18% in 2030 across the 33 OECD countries, with resistance to second- and third-line antibiotics expected to be 70% higher by 2030.
Nationwide survey in Japan finds deep misconceptions about antibiotics
7 NOV - via CIDRAP
A nationwide survey in Japan has found that misconceptions about antimicrobials and antimicrobial resistance (AMR) abound, and many have taken antimicrobials inappropriately, with almost half having obtained antibiotics for the common cold.